Annual FCF
$8.01 B
-$338.00 M-4.05%
31 December 2023
Summary:
Gilead Sciences annual free cash flow is currently $8.01 billion, with the most recent change of -$338.00 million (-4.05%) on 31 December 2023. During the last 3 years, it has risen by +$488.00 million (+6.49%). GILD annual FCF is now -60.95% below its all-time high of $20.50 billion, reached on 31 December 2015.GILD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$4.17 B
+$2.97 B+248.79%
30 September 2024
Summary:
Gilead Sciences quarterly free cash flow is currently $4.17 billion, with the most recent change of +$2.97 billion (+248.79%) on 30 September 2024. Over the past year, it has increased by +$2.54 billion (+155.24%). GILD quarterly FCF is now -25.95% below its all-time high of $5.63 billion, reached on 31 December 2015.GILD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$9.43 B
+$2.54 B+36.76%
30 September 2024
Summary:
Gilead Sciences TTM free cash flow is currently $9.43 billion, with the most recent change of +$2.54 billion (+36.76%) on 30 September 2024. Over the past year, it has increased by +$1.58 billion (+20.09%). GILD TTM FCF is now -54.00% below its all-time high of $20.50 billion, reached on 31 December 2015.GILD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GILD Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.0% | +155.2% | +20.1% |
| 3 y3 years | +6.5% | +33.9% | -0.6% |
| 5 y5 years | +7.1% | +70.5% | +17.3% |
GILD Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -25.9% | +6.5% | at high | +248.8% | -12.7% | +36.8% |
| 5 y | 5 years | -25.9% | +7.1% | at high | +248.8% | -12.7% | +36.8% |
| alltime | all time | -61.0% | +5322.1% | -25.9% | +2829.8% | -54.0% | +6251.6% |
Gilead Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.17 B(+248.8%) | $9.43 B(+36.8%) |
| June 2024 | - | $1.20 B(-43.5%) | $6.90 B(-12.7%) |
| Mar 2024 | - | $2.11 B(+8.2%) | $7.90 B(+6.5%) |
| Dec 2023 | $8.01 B(-4.1%) | $1.95 B(+19.7%) | $7.42 B(-5.5%) |
| Sept 2023 | - | $1.63 B(-25.7%) | $7.85 B(-12.0%) |
| June 2023 | - | $2.20 B(+34.5%) | $8.93 B(+6.4%) |
| Mar 2023 | - | $1.64 B(-31.5%) | $8.39 B(+0.5%) |
| Dec 2022 | $8.34 B(-22.8%) | $2.39 B(-11.8%) | $8.34 B(-7.4%) |
| Sept 2022 | - | $2.71 B(+63.1%) | $9.01 B(-4.3%) |
| June 2022 | - | $1.66 B(+4.1%) | $9.41 B(-5.4%) |
| Mar 2022 | - | $1.59 B(-47.8%) | $9.95 B(-7.9%) |
| Dec 2021 | $10.80 B(+43.7%) | $3.05 B(-2.1%) | $10.80 B(+13.8%) |
| Sept 2021 | - | $3.11 B(+41.7%) | $9.49 B(+12.0%) |
| June 2021 | - | $2.20 B(-10.1%) | $8.47 B(-2.6%) |
| Mar 2021 | - | $2.44 B(+40.9%) | $8.70 B(+15.7%) |
| Dec 2020 | $7.52 B(-9.6%) | $1.74 B(-17.2%) | $7.52 B(-7.9%) |
| Sept 2020 | - | $2.10 B(-13.5%) | $8.16 B(-4.1%) |
| June 2020 | - | $2.42 B(+91.5%) | $8.51 B(+3.2%) |
| Mar 2020 | - | $1.26 B(-46.8%) | $8.24 B(-0.9%) |
| Dec 2019 | $8.32 B(+11.3%) | $2.38 B(-2.8%) | $8.32 B(+3.5%) |
| Sept 2019 | - | $2.44 B(+13.4%) | $8.04 B(+5.2%) |
| June 2019 | - | $2.16 B(+61.0%) | $7.64 B(+13.0%) |
| Mar 2019 | - | $1.34 B(-36.1%) | $6.76 B(-9.6%) |
| Dec 2018 | $7.48 B(-33.9%) | $2.10 B(+2.5%) | $7.48 B(-5.5%) |
| Sept 2018 | - | $2.04 B(+60.3%) | $7.91 B(-6.2%) |
| June 2018 | - | $1.28 B(-38.0%) | $8.43 B(-20.1%) |
| Mar 2018 | - | $2.06 B(-18.8%) | $10.56 B(-6.6%) |
| Dec 2017 | $11.31 B(-30.6%) | $2.53 B(-1.2%) | $11.31 B(-6.9%) |
| Sept 2017 | - | $2.56 B(-24.6%) | $12.14 B(-11.8%) |
| June 2017 | - | $3.40 B(+21.2%) | $13.78 B(-9.1%) |
| Mar 2017 | - | $2.81 B(-16.7%) | $15.15 B(-7.0%) |
| Dec 2016 | $16.30 B(-20.5%) | $3.37 B(-19.7%) | $16.30 B(-12.2%) |
| Sept 2016 | - | $4.20 B(-12.3%) | $18.56 B(+2.1%) |
| June 2016 | - | $4.78 B(+20.9%) | $18.17 B(-3.7%) |
| Mar 2016 | - | $3.95 B(-29.8%) | $18.88 B(-7.9%) |
| Dec 2015 | $20.50 B(+67.2%) | $5.63 B(+47.7%) | $20.50 B(+15.7%) |
| Sept 2015 | - | $3.81 B(-30.6%) | $17.73 B(-0.6%) |
| June 2015 | - | $5.49 B(-1.6%) | $17.83 B(+8.5%) |
| Mar 2015 | - | $5.58 B(+95.4%) | $16.43 B(+34.0%) |
| Dec 2014 | $12.26 B(+320.6%) | $2.85 B(-27.0%) | $12.26 B(+21.8%) |
| Sept 2014 | - | $3.91 B(-4.5%) | $10.07 B(+46.5%) |
| June 2014 | - | $4.09 B(+191.6%) | $6.87 B(+86.4%) |
| Mar 2014 | - | $1.40 B(+113.3%) | $3.69 B(+26.4%) |
| Dec 2013 | $2.92 B(+4.2%) | $658.11 M(-8.1%) | $2.92 B(+8.2%) |
| Sept 2013 | - | $715.92 M(-21.1%) | $2.69 B(+1.4%) |
| June 2013 | - | $907.73 M(+43.3%) | $2.66 B(-11.5%) |
| Mar 2013 | - | $633.25 M(+45.2%) | $3.00 B(+7.3%) |
| Dec 2012 | $2.80 B(-20.2%) | $436.19 M(-35.7%) | $2.80 B(-15.6%) |
| Sept 2012 | - | $678.78 M(-45.8%) | $3.31 B(-4.4%) |
| June 2012 | - | $1.25 B(+191.6%) | $3.47 B(+10.8%) |
| Mar 2012 | - | $429.77 M(-54.9%) | $3.13 B(-10.7%) |
| Dec 2011 | $3.51 B(+26.5%) | $952.00 M(+14.3%) | $3.51 B(+7.7%) |
| Sept 2011 | - | $832.82 M(-9.1%) | $3.26 B(+3.3%) |
| June 2011 | - | $916.62 M(+13.8%) | $3.15 B(+8.0%) |
| Mar 2011 | - | $805.67 M(+14.9%) | $2.92 B(+5.3%) |
| Dec 2010 | $2.77 B(-2.7%) | $701.48 M(-3.7%) | $2.77 B(-7.6%) |
| Sept 2010 | - | $728.62 M(+6.7%) | $3.00 B(-3.7%) |
| June 2010 | - | $683.03 M(+3.7%) | $3.11 B(+2.7%) |
| Mar 2010 | - | $658.90 M(-29.0%) | $3.03 B(+6.4%) |
| Dec 2009 | $2.85 B(+40.5%) | $928.29 M(+10.2%) | $2.85 B(+15.6%) |
| Sept 2009 | - | $842.41 M(+39.9%) | $2.46 B(+17.2%) |
| June 2009 | - | $602.04 M(+26.1%) | $2.10 B(+9.7%) |
| Mar 2009 | - | $477.26 M(-12.1%) | $1.92 B(-5.5%) |
| Dec 2008 | $2.03 B | $543.10 M(+13.0%) | $2.03 B(+2.5%) |
| Sept 2008 | - | $480.65 M(+15.6%) | $1.98 B(+13.9%) |
| June 2008 | - | $415.87 M(-29.4%) | $1.74 B(-4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $588.76 M(+19.5%) | $1.81 B(+7.3%) |
| Dec 2007 | $1.69 B(+51.6%) | $492.66 M(+106.4%) | $1.69 B(+2.6%) |
| Sept 2007 | - | $238.70 M(-51.3%) | $1.64 B(+1.8%) |
| June 2007 | - | $489.93 M(+5.3%) | $1.61 B(+17.8%) |
| Mar 2007 | - | $465.45 M(+3.6%) | $1.37 B(+23.2%) |
| Dec 2006 | $1.11 B(+69.2%) | $449.30 M(+114.6%) | $1.11 B(+13.4%) |
| Sept 2006 | - | $209.35 M(-15.1%) | $981.52 M(+58.4%) |
| June 2006 | - | $246.57 M(+18.8%) | $619.49 M(-4.2%) |
| Mar 2006 | - | $207.64 M(-34.7%) | $646.98 M(-1.6%) |
| Dec 2005 | $657.69 M(+44.0%) | $317.97 M(-308.2%) | $657.69 M(+50.1%) |
| Sept 2005 | - | -$152.69 M(-155.7%) | $438.09 M(-41.3%) |
| June 2005 | - | $274.06 M(+25.5%) | $746.51 M(+28.2%) |
| Mar 2005 | - | $218.35 M(+122.0%) | $582.10 M(+27.5%) |
| Dec 2004 | $456.60 M(+133.0%) | $98.36 M(-36.8%) | $456.60 M(-15.8%) |
| Sept 2004 | - | $155.74 M(+42.0%) | $542.54 M(+66.5%) |
| June 2004 | - | $109.65 M(+18.1%) | $325.92 M(+20.5%) |
| Mar 2004 | - | $92.85 M(-49.6%) | $270.58 M(+38.1%) |
| Dec 2003 | $196.00 M(+245.0%) | $184.30 M(-402.7%) | $196.00 M(+364.8%) |
| Sept 2003 | - | -$60.88 M(-212.1%) | $42.17 M(-73.6%) |
| June 2003 | - | $54.30 M(+197.2%) | $159.56 M(+57.6%) |
| Mar 2003 | - | $18.27 M(-40.0%) | $101.23 M(+78.2%) |
| Dec 2002 | $56.81 M(-137.1%) | $30.47 M(-46.1%) | $56.81 M(-423.7%) |
| Sept 2002 | - | $56.52 M(-1502.0%) | -$17.55 M(-84.2%) |
| June 2002 | - | -$4.03 M(-84.6%) | -$110.79 M(-24.1%) |
| Mar 2002 | - | -$26.14 M(-40.4%) | -$145.95 M(-4.8%) |
| Dec 2001 | -$153.31 M(+184.8%) | -$43.89 M(+19.5%) | -$153.31 M(+12.0%) |
| Sept 2001 | - | -$36.72 M(-6.3%) | -$136.88 M(+18.5%) |
| June 2001 | - | -$39.20 M(+17.0%) | -$115.52 M(+48.0%) |
| Mar 2001 | - | -$33.50 M(+22.0%) | -$78.04 M(+45.0%) |
| Dec 2000 | -$53.82 M(-28.3%) | -$27.45 M(+78.7%) | -$53.82 M(+33.7%) |
| Sept 2000 | - | -$15.36 M(+791.6%) | -$40.27 M(-17.2%) |
| June 2000 | - | -$1.72 M(-81.4%) | -$48.61 M(-29.3%) |
| Mar 2000 | - | -$9.28 M(-33.2%) | -$68.75 M(-8.4%) |
| Dec 1999 | -$75.10 M(+20.5%) | -$13.90 M(-41.4%) | -$75.10 M(-0.9%) |
| Sept 1999 | - | -$23.70 M(+8.4%) | -$75.80 M(-12.1%) |
| June 1999 | - | -$21.87 M(+39.9%) | -$86.20 M(+22.6%) |
| Mar 1999 | - | -$15.63 M(+7.0%) | -$70.33 M(+12.9%) |
| Dec 1998 | -$62.30 M(-8.8%) | -$14.60 M(-57.2%) | -$62.30 M(-40.8%) |
| Sept 1998 | - | -$34.10 M(+468.3%) | -$105.20 M(+30.0%) |
| June 1998 | - | -$6.00 M(-21.1%) | -$80.90 M(+5.6%) |
| Mar 1998 | - | -$7.60 M(-86.8%) | -$76.60 M(+12.2%) |
| Dec 1997 | -$68.30 M(+238.1%) | -$57.50 M(+486.7%) | -$68.30 M(+658.9%) |
| Sept 1997 | - | -$9.80 M(+476.5%) | -$9.00 M(-3100.0%) |
| June 1997 | - | -$1.70 M(-342.9%) | $300.00 K(-102.6%) |
| Mar 1997 | - | $700.00 K(-61.1%) | -$11.60 M(-42.6%) |
| Dec 1996 | -$20.20 M(-14.4%) | $1.80 M(-460.0%) | -$20.20 M(-8.2%) |
| Sept 1996 | - | -$500.00 K(-96.3%) | -$22.00 M(-19.7%) |
| June 1996 | - | -$13.60 M(+72.2%) | -$27.40 M(+24.5%) |
| Mar 1996 | - | -$7.90 M(+33.9%) | -$22.00 M(-29.0%) |
| Dec 1995 | -$23.60 M(-24.6%) | - | - |
| Sept 1995 | - | -$5.90 M(-28.0%) | -$31.00 M(+1.3%) |
| June 1995 | - | -$8.20 M(+6.5%) | -$30.60 M(-2.2%) |
| Mar 1995 | - | -$7.70 M(-16.3%) | -$31.30 M(+2.0%) |
| Mar 1995 | -$31.30 M(+22.3%) | - | - |
| Dec 1994 | - | -$9.20 M(+67.3%) | -$30.70 M(+8.9%) |
| Sept 1994 | - | -$5.50 M(-38.2%) | -$28.20 M(+3.7%) |
| June 1994 | - | -$8.90 M(+25.4%) | -$27.20 M(+6.3%) |
| Mar 1994 | -$25.60 M(+92.5%) | -$7.10 M(+6.0%) | -$25.60 M(-2.3%) |
| Dec 1993 | - | -$6.70 M(+48.9%) | -$26.20 M(+12.9%) |
| Sept 1993 | - | -$4.50 M(-38.4%) | -$23.20 M(+27.5%) |
| June 1993 | - | -$7.30 M(-5.2%) | -$18.20 M(+36.8%) |
| Mar 1993 | -$13.30 M(+216.7%) | -$7.70 M(+108.1%) | -$13.30 M(+137.5%) |
| Dec 1992 | - | -$3.70 M(-840.0%) | -$5.60 M(+194.7%) |
| Sept 1992 | - | $500.00 K(-120.8%) | -$1.90 M(-20.8%) |
| June 1992 | - | -$2.40 M | -$2.40 M |
| Mar 1992 | -$4.20 M(+55.6%) | - | - |
| Mar 1991 | -$2.70 M | - | - |
FAQ
- What is Gilead Sciences annual free cash flow?
- What is the all time high annual FCF for Gilead Sciences?
- What is Gilead Sciences annual FCF year-on-year change?
- What is Gilead Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Gilead Sciences?
- What is Gilead Sciences quarterly FCF year-on-year change?
- What is Gilead Sciences TTM free cash flow?
- What is the all time high TTM FCF for Gilead Sciences?
- What is Gilead Sciences TTM FCF year-on-year change?
What is Gilead Sciences annual free cash flow?
The current annual FCF of GILD is $8.01 B
What is the all time high annual FCF for Gilead Sciences?
Gilead Sciences all-time high annual free cash flow is $20.50 B
What is Gilead Sciences annual FCF year-on-year change?
Over the past year, GILD annual free cash flow has changed by -$338.00 M (-4.05%)
What is Gilead Sciences quarterly free cash flow?
The current quarterly FCF of GILD is $4.17 B
What is the all time high quarterly FCF for Gilead Sciences?
Gilead Sciences all-time high quarterly free cash flow is $5.63 B
What is Gilead Sciences quarterly FCF year-on-year change?
Over the past year, GILD quarterly free cash flow has changed by +$2.54 B (+155.24%)
What is Gilead Sciences TTM free cash flow?
The current TTM FCF of GILD is $9.43 B
What is the all time high TTM FCF for Gilead Sciences?
Gilead Sciences all-time high TTM free cash flow is $20.50 B
What is Gilead Sciences TTM FCF year-on-year change?
Over the past year, GILD TTM free cash flow has changed by +$1.58 B (+20.09%)